Skip to main content

Table 3 EORTC-C30 and -BN20 domain and single item's scores before and 3 months after VMAT

From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

QoL

Pre-VMAT scoren ± SD

Score during VMAT ± SD

p value

C30

   

Global Health Status

65.4 ± 22.8

60.1 ± 26.6

0.72

Physical functioning

81.4 ± 17.6

63.3 ± 29.8

0.05

Emotional functioning

77.7 ± 21.2

74.4 ± 26.2

0.91

Role functioning

72.6 ± 22.3

45.2 ± 37.8

0.01

BN20 domains/items

   

Domains

   

Future uncertainty

27.1 ± 20.7

27.4 ± 31.6

0.66

Visual disorder

12.7 ± 21.3

15.1 ± 21.2

0.25

Motor dysfunction

21.4 ± 24.8

22.2 ± 33.5

0.96

Communication deficit

23.0 ± 30.3

27.8 ± 29.5

0.55

Single items

   

Headache

33.3 ± 37.0

7.1 ± 14.2

< 0.05

Hair loss

14.3 ± 31.2

23.8 ± 30.5

0.48

Weakness of legs

21.4 ± 24.8

28.6 ± 34.2

0.39

Bladder control

21.4 ± 33.6

11.9 ± 24.8

0.26

  1. Abbreviations: QoL: Quality of life; SD, standard deviation.